CONTINENTAL ADVISORS LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1277779 Park City, UT

Back to TEVA Full portfolio

Position in TEVA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$7,292,594

-$1,699,568 QoQ

Shares Held

242,118

-16.0% QoQ

Ownership

0.021%

of shares outstanding

% of Portfolio

4.34%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Derivatives in TEVA

reported options exposure · as of Dec 31, 2023

CallValue

$3,188,376

CallShares

305,400

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CONTINENTAL ADVISORS LLC holds $23,793,973 across 3 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (30.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	888,750	$12,007,012
2	TEVA	Teva Pharmaceutical Industries Ltd This page	242,118	$7,292,594
3	PRGO	PERRIGO Co plc	418,470	$4,494,367

All Filings in TEVA

Export CSV

39 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,292,594	242,118	-16.0%	Shares	Sole	2026-05-15
2025-12-31	$8,992,162	288,118	-15.5%	Shares	Sole	2026-02-12
2025-09-30	$6,890,583	341,118	0.0%	Shares	Sole	2025-11-03
2025-06-30	$5,717,137	341,118	0.0%	Shares	Sole	2025-08-19
2025-03-31	$5,242,983	341,118	0.0%	Shares	Sole	2025-05-16
2024-12-31	$7,518,240	341,118	-5.7%	Shares	Sole	2025-02-14
2024-09-30	$6,516,356	361,618	-10.4%	Shares	Sole	2024-11-14
2024-06-30	$6,561,197	403,766	-15.5%	Shares	Sole	2024-08-14
2024-03-31	$6,741,278	477,766	+51.7%	Shares	Sole	2024-05-15
2023-12-31	$3,287,201	314,866	+3.1%	Shares	Sole	2024-02-14
2023-12-31	$3,188,376	305,400	-10.4%	Call	Sole	2024-02-14
2023-09-30	$3,476,833	340,866	+119.3%	Shares	Sole	2023-11-14
2023-09-30	$1,585,080	155,400	-62.4%	Call	Sole	2023-11-14
2023-06-30	$3,112,645	413,366	+60.8%	Shares	Sole	2023-08-14
2023-06-30	$1,935,210	257,000	-30.5%	Call	Sole	2023-08-14
2023-03-31	$3,272,730	369,800	+143.9%	Shares	Sole	2023-05-15
2023-03-31	$1,341,660	151,600	-50.5%	Call	Sole	2023-05-15
2022-12-31	$2,793,456	306,300	+104.2%	Shares	Sole	2023-02-14
2022-12-31	$1,368,000	150,000	-38.7%	Call	Sole	2023-02-14
2022-09-30	$1,973,115	244,500	+39.5%	Call	Sole	2022-11-14
2022-09-30	$1,414,671	175,300	-30.8%	Shares	Sole	2022-11-14
2022-06-30	$1,906,214	253,486	+3.7%	Shares	Sole	2022-08-15
2022-06-30	$1,838,640	244,500	-12.2%	Call	Sole	2022-08-15
2022-03-31	$2,614,983	278,486	+13.9%	Shares	Sole	2022-05-16
2022-03-31	$2,295,855	244,500	-15.2%	Call	Sole	2022-05-16
2021-12-31	$2,310,772	288,486	-20.9%	Shares	Sole	2022-02-14
2021-12-31	$2,921,247	364,700	+26.4%	Call	Sole	2022-02-14
2021-09-30	$2,809,853	288,486	-29.7%	Shares	Sole	2021-11-15
2021-09-30	$3,995,348	410,200	+58.1%	Call	Sole	2021-11-15
2021-06-30	$2,568,911	259,486	-9.7%	Shares	Sole	2021-08-16
2021-06-30	$2,846,250	287,500	+15.2%	Call	Sole	2021-08-16
2021-03-31	$2,879,068	249,486	+29.9%	Shares	Sole	2021-05-17
2021-03-31	$2,215,680	192,000	-26.0%	Call	Sole	2021-05-17
2020-12-31	$2,504,039	259,486	+765.0%	Shares	Sole	2021-02-16
2020-12-31	$289,500	30,000	-57.1%	Call	Sole	2021-02-16
2020-09-30	$630,700	70,000	-47.4%	Call	Sole	2020-11-16
2020-09-30	$1,200,005	133,186	-18.4%	Shares	Sole	2020-11-16
2020-06-30	$2,012,083	163,186	0.0%	Shares	Sole	2020-08-14
2020-03-31	$1,465,410	163,186	—	Shares	Sole	2020-05-08
No filing history on record for this holder in this stock.